14th EFLM Continuing Postgraduate Course in Clinical Chemistry and Laboratory Medicine - Dubrovnik, October 25-26, 2014
The 14th EFLM Course “New trends in laboratory diagnosis and management of diabetes mellitus: Diabetes mellitus revisited 14 years after the first Dubrovnik course” is organised in Dubrovnik on October 25-26, 2014. It will bring a lot of new information documenting the progress in the field of diagnosis and management of Diabetes Mellitus in the period of 14 years, when the Diabetes Mellitus was the subject of the first EFLM Course. The program is designed to be interesting and brings together Europe’s specialist trained in laboratory medicine and physicians focused on Diabetes Mellitus and its complications, one of the most frequent diseases worldwide. It will be an opportunity not only to listen to renowned experts in the field, but also for young participants to present their experience and results in the form of poster, reflecting their contribution to diabetic care across Europe.
We believe that for now, this is enough information for you to note the date of this event and plan your participation accordingly. The registration fee is low enough to encourage you to do it. More information you can find at the following link: www.dubrovnik-course.org
We would like to draw your attention on the following dates:
Abstract submission - June 15, 2014
Bursary application deadline – July 15, 2014
Early registration fee – August 1, 2014
We look forward to welcome you in Dubrovnik!
BIAS and hypertriglyceridemia effect on risk score: an important study by the EAS-EFLM Cardiac Marker WG collaborative project group
A crucial study of the clinical impact of method bias in the cardiovascular risk classification based on HDL and LDL measurements in hypertriglyceridemia has been recently published in Atherosclerosis 2014;233:83-90. The study is part of the Collaborative Project Group between European Atherosclerosis Society (EAS) and EFLM, established by A Catapano (EAS President), J Chapman (EAS Past-president), and S Sandberg (previous EFLM Chair of Scientific Division, now EFLM President Elect) “…to produce laboratory testing recommendations and guidelines for management of dyslipidemia and prevention of cardiovascular disease”. Examining the results of a National External Quality Assessment, the group observed that direct HDL and LDL measurements are unreliable in hypertriglyceridemia and that these values should be used with caution in the SCORE risk classification and in related therapeutic approaches. The study deserves particular attention since it addresses the clinical outcomes of laboratory activities and emphasizes competencies in the interpretation of laboratory tests and in the invaluable role that Clinical Chemists may play in optimizing patient outcome.
Read the Abstract at http://www.atherosclerosis-journal.com/article/S0021-9150(13)00769-7/abstract
EFLM bursaries - 3rd EFLM-UEMS European Joint Congress in Liverpool
This is to announce that EFLM is promoting 5 bursaries for young scientists attending the:
3rd EFLM-UEMS European Joint Congress Laboratory medicine at the clinical interface
7-10 October 2014 - Liverpool, UK
The bursaries will cover the cost of the travel, 3-night accommodation and registration fee for a maximum of Eur 1200. Eligible candidates must come from an EFLM Member Society and meet the following criteria:
1) Young participants (those in training or up to 5 years after completing training);
2) Having a poster abstract accepted.
Please send your applications to email@example.com within July 10, 2014.
Applicants will be notified of the bursaries acceptance by 15 July 2014.
Applications must be accompanied with:
1) Short CV,
2) Copy of the ID or passport,
3) List of publications,
4) Letter of recommendation from the National Society,
5) Notification of poster acceptance.
Preference shall be given to candidates with publications in Scientific Journals with high IF.
EFLM Walter Guder Preanalytical Award
EFLM is pleased to announce a call for Walter Guder Preanalytical Award for the best preanalytical original paper published between 1 January 2013 and 30 April 2014. The applicants should be members of the EFLM member societies and in the age of <40 years.
For all details about the award please take a look at the leaflet by clicking here.
Your applications should be submitted to EFLM office at firstname.lastname@example.org by May 1, 2014.
We look forward to receive your proposals!
EU Directive 2005/36/EC: A new horizon to working across the European community
At a time when demand for highly qualified professionals across the EU is increasing and the labour force is declining, EFLM welcomes the passage in December 2013 of Directive 2005/36/EC (The recognition of professional qualifications) through the EU’s Parliament, Council and Commission. In supporting professional mobility across EU borders the Directive is a catalyst to ensuring a more equitable distribution of knowledge and skills across the community’s member states. EFLM’s Profession Committee will be at the forefront of shaping a common training framework for specialists in laboratory medicine and defining the equivalence of standards that ensures patients receive high quality, safe and equitable services wherever they are in the Community. The consolidated text for the Directive can be accessed at by clicking here.
For EFLM/EC4 national societies the passage of the Directive represents an opportunity for 9 EU member states to work with their governments to present the framework to the EU Commission. EU national societies are encouraged to liaise with their EC4 representatives for guidance on becoming a candidate state. In developing a common training framework EC4’s syllabus for education, training, knowledge and competency expectations represent the building blocks to which the input of all relevant stakeholders (email@example.com) will be also welcomed as we work to support the transposition of the Directive into national law.
EFLM Working Group on Cardiac Markers - Chair: Paivi Laitinen (FI)
The EFLM working group cardiac markers (EFLM-WG-CM) was originally constituted in 2010 with the brief to undertake an audit of current practice in cardiac biomarker testing in EFLM members via the national Clinical Chemistry/Biochemistry Societies. To date, we have undertaken three such surveys. On behalf on the WG-CM members we would like to extend our sincere thanks to all of those who have participated in the surveys. We all know that everyone is forever bombarded with surveys so we are very grateful to all who have participated. To those of you that have not, we would ask you to consider participating next time. We try and keep the surveys simple and they are web based. Read More - See also the slides posted by this WG
Report from the EFLM WG on Preanalytical Phase
The pre- and post-analytical phases of the laboratory testing process are now widely recognized as the major sources of laboratory errors. Preanalytical errors are the most common and account for up to 2/3 of the total number of errors. The risk of error in the laboratory testing process is underestimated in everyday clinical practice. The European Federation of Clinical Chemistry and Laboratory medicine (EFLM) working group on the preanalytical phase (WG-PRE) was established in 2010 to work on reducing the risk. Efficient indicators and educational tools are needed in order to implement the best preanalytical practices. Read More
EuroLabFocus 2014 - Liverpool, 7-10 October 2014
Abstract submission and registration is now open on the web site at www.eurolabfocus2014.org
The deadline to submit abstracts is Friday 16th May 2014 while to take advantage of the reduced registration rates, registration forms must be returned by 1st August 2014.
Renewal of the agreement with CCLM
It is a pleasure to announce that the agreement on mutual cooperation between the European Federation of Laboratory Medicine (EFLM) and the Journal Clinical Chemistry and Laboratory Medicine (CCLM) has been renewed for the duration of another 5 years (2014-2018). CCLM is published on a monthly basis and is the most relevant Journal on Clinical Chemistry in Europe and is a valuable and updated source of knowledge for the scientific community and professionals in the field well recognized all over the world. The CCLM 2012 Impact factor is 3.009. Read more